Glaukos Releases Its 2024 Sustainability Report

Published on April 23, 2025
ALISO VIEJO, Calif.—Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company developing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced that it has published its 2024 Sustainability Report.
Continue reading on website
Other news

NOA Midwestern Symposium 2025: Knowing when to refer when post-trabeculectomy complications arise

April 22, 2025
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.

Bausch + Lomb recycles a total of over 625,000 pounds of contact lenses and eye care products

April 23, 2025
The ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 103,169,500 units.